• Attending Physician, Department of Otolaryngology, National Taiwan University Hospital.

• Otolaryngology
• Head and neck oncology
• Head and neck surgery

• MD, School of Medicine, National Taiwan University.

• Clinical Instructor, College of Medicine, National Taiwan University.
• Attending Physician, Department of Otolaryngology, National Taiwan University Hospital Hsin-Chu Branch.
• Attending Physician, Department of Otolaryngology, National Taiwan University Hospital, Jin-Shan Branch
• Chief Resident, Department of Otolaryngology, National Taiwan University Hospital.

According to the 2020 statistics on causes of death from the Ministry of Health and Welfare, head and neck cancer ranked as the third most common cancer in men. The majority of affected individuals are males aged from 40s to 60s. However, more than half of the patients with head and neck squamous cell carcinoma are locally advanced cancers at initial diagnosis. Both the disease itself and the treatment process severely impact the appearance and function, such as chewing, swallowing, and speaking.

Therefore, in addition to quitting harmful habits such as smoking, alcohol consumption, and betel nut chewing, regular oral screenings and human papillomavirus (HPV) vaccinations (specifically for oropharyngeal cancer) can help enable early diagnosis or prevention of oral and oropharyngeal cancers. Moreover, there are currently various surgical treatments available for head and neck cancers, including traditional surgery, endoscopic surgery, micro-laser surgery, and robotic-assisted surgery. There are also new medical treatments, such as target therapy and immunotherapy.

In the era of precision medicine, it is essential to discuss the personalized treatment plan of head and neck cancer with your physician.